三生国健：8月29日召开董事会会议

Group 1 - The company Sanofi Guojian (SH 688336) held its 11th meeting of the 5th board of directors on August 29, 2025, to review the semi-annual evaluation report of the "Quality Improvement and Efficiency Return Action Plan for 2025" [1] - For the year 2024, the revenue composition of Sanofi Guojian is as follows: pharmaceutical manufacturing accounts for 83.02%, CDMO business accounts for 10.19%, licensing accounts for 5.54%, and other businesses account for 1.25% [1] - As of the report date, the market capitalization of Sanofi Guojian is 32.4 billion yuan [1] Group 2 - The article mentions the upcoming A-level car exhibition in Southwest China, which will feature nearly 120 brands and 1,600 vehicles, indicating a competitive landscape in the new energy vehicle market [1]